Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1243.51x is 50% above its 2-year average of -2505.92x, near the high end of its 2-year range (-16263.87x–-1.58x).
As of the fiscal period ended Thursday, September 30, 2021. 64.54% above its 12-month average of -3507.14x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2021 (2021-09-30): -1243.51x.
INTEREST COVERAGE RATIO
-1243.51x
INTEREST COVERAGE RATIO AVG TTM
-3507.14x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+64.54%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.07x
median of 333 covered companies
CURRENT VS SECTOR MEDIAN
-30452.99%
vs the sector median at left
Context Therapeutics Inc.
Market Cap
$31.14M
Interest Coverage Ratio
-1243.51x
TTM Avg
-3507.14x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.11M
Interest Coverage Ratio
N/A
TTM Avg
1.23x
3Y Avg
1.23x
5Y Avg
1.23x
Market Cap
$30.81M
Interest Coverage Ratio
-34.63x
TTM Avg
34.14x
3Y Avg
47.81x
5Y Avg
52.62x
Market Cap
$32.55M
Interest Coverage Ratio
-10.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29.24M
Interest Coverage Ratio
-14.43x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.85M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | $31.14M | -1243.51x | -3507.14x | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $31.11M | N/A | 1.23x | 1.23x | 1.23x |
| BeyondSpring Inc. (BYSI)vs › | $31.35M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.81M | -34.63x | 34.14x | 47.81x | 52.62x |
| EUDA Health Holdings Limited (EUDA)vs › | $32.55M | -10.67x | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.24M | -14.43x | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.79M | N/A | N/A | N/A | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | N/A | N/A | N/A | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.85M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $34.65M | N/A | 8.27x | 8.27x | 8.27x |
Interest Coverage
-1243.5x
Debt/Equity
0.01
Current Ratio
5.81
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -1243.51x |
| 2021-06-30 | -16263.87x |
| 2021-03-31 | -13.34x |
| 2020-12-31 | -8.15x |
| 2020-09-30 | -6.84x |
| 2020-06-30 | -4.19x |
| 2020-03-31 | -1.58x |
